Fortis Healthcare Share Price
Sector: Healthcare Facilities
478.35 -3.00 (-0.62%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
473.8
Today’s High
492
52 Week Low
298
52 Week High
509.85
478.30 -3.00 (-0.62%)
- 1D
- 5D
- 1M
- 3M
- 6M
- 1Y
- 5Y
- MAX
Price Range
Today’s Low
473.45
Today’s High
492.25
52 Week Low
298.45
52 Week High
509.85
Key Metrics
- Market Cap (In Cr) 36336.13
- Beta 0.87
- Div. Yield (%) 0.21
- P/B 4.74
- TTM P/E 52.99
- Peg Ratio 1.8
- Sector P/E 27.33
- D/E 0.15
- Open Price 481.35
- Prev Close 481.35
Fortis Healthcare Analysis
Price Analysis
-
1 Week-1.94%
-
3 Months13.83%
-
6 Month18.01%
-
YTD14.1%
-
1 Year56.79%
Risk Meter
- 33% Low risk
- 33% Moderate risk
- 33% Balanced Risk
- 33% High risk
- 33% Extreme risk
Recos
- Strong Sell
- Sell
- Hold
- Buy
- Strong Buy
Analysts' Views
- Ratings
- Current
- 1 W Ago
- 1 M Ago
- 3 M Ago
- Strong Buy
- 3
- 3
- 3
- 3
- Buy
- 8
- 8
- 8
- 8
- Hold
- 1
- 1
- 1
- 0
- Sell
- 0
- 0
- 0
- 0
- Strong Sell
- 0
- 0
- 0
- 0
- Total
- 12
- 12
- 12
- 11
Fortis Healthcare News
Stocks to watch: Steel Strips, Metro, Zaggle, Yatharth Hosp., Ritco Logistics
7 min read . 24 May 2024Q4 Results Today: IndiGo, ITC, ICRA among 181 companies to post earnings today
2 min read . 23 May 2024Apollo, Fortis, Max Healthcare share prices rise 42-84% in a year: Buy or Sell?
2 min read . 26 Apr 2024Fortis Malar Hospitals, Aster DM Healthcare, shares to trade ex-dividend today
2 min read . 23 Apr 2024Fortis Healthcare Financials
- INCOME
- BALANCE SHEET
- Cashflow
- Period
- 2024
- Total Revenue
- 6892.92
- Selling/ General/ Admin Expenses Total
- 2579.04
- Depreciation/ Amortization
- 342.5
- Other Operating Expenses Total
- 1427.56
- Total Operating Expense
- 5951.76
- Operating Income
- 941.16
- Net Income Before Taxes
- 857.97
- Net Income
- 598.88
- Diluted Normalized EPS
- 7.77
- Period
- 2024
- Total Assets
- 13288.78
- Total Liabilities
- 5625.88
- Total Equity
- 7662.9
- Tangible Book Valueper Share Common Eq
- 40.47
- Period
- 2024
- Cashfrom Operating Activities
- 1100.08
- Cashfrom Investing Activities
- -886.35
- Cashfrom Financing Activities
- -86.46
- Net Changein Cash
- 124.52
- Period
- 2023
- Total Revenue
- 6297.63
- Selling/ General/ Admin Expenses Total
- 3504.95
- Depreciation/ Amortization
- 315.74
- Other Operating Expenses Total
- 11.43
- Total Operating Expense
- 5438.42
- Operating Income
- 859.22
- Net Income Before Taxes
- 813.68
- Net Income
- 588.73
- Diluted Normalized EPS
- 6.87
- Period
- 2023
- Total Assets
- 12433.6
- Total Liabilities
- 5191.34
- Total Equity
- 7242.26
- Tangible Book Valueper Share Common Eq
- 35.3
- Period
- 2023
- Cashfrom Operating Activities
- 822.22
- Cashfrom Investing Activities
- -373.7
- Cashfrom Financing Activities
- -471.22
- Net Changein Cash
- -21.46
- Period
- 2022
- Total Revenue
- 5717.61
- Selling/ General/ Admin Expenses Total
- 3063.26
- Depreciation/ Amortization
- 300.84
- Other Operating Expenses Total
- 11.16
- Total Operating Expense
- 4642.55
- Operating Income
- 1075.06
- Net Income Before Taxes
- 987.79
- Net Income
- 555.12
- Diluted Normalized EPS
- 3.98
- Period
- 2022
- Total Assets
- 11884.75
- Total Liabilities
- 5706.51
- Total Equity
- 6178.24
- Tangible Book Valueper Share Common Eq
- 22.69
- Period
- 2022
- Cashfrom Operating Activities
- 879.11
- Cashfrom Investing Activities
- -514.38
- Cashfrom Financing Activities
- -517.31
- Net Changein Cash
- -152.52
- Period
- 2021
- Total Revenue
- 4030.12
- Selling/ General/ Admin Expenses Total
- 2424.81
- Depreciation/ Amortization
- 290.6
- Other Operating Expenses Total
- 24.06
- Total Operating Expense
- 3902.96
- Operating Income
- 127.16
- Net Income Before Taxes
- 43.3
- Net Income
- -109.76
- Diluted Normalized EPS
- -1.48
- Period
- 2021
- Total Assets
- 11154.69
- Total Liabilities
- 5034.88
- Total Equity
- 6119.81
- Tangible Book Valueper Share Common Eq
- 30.92
- Period
- 2021
- Cashfrom Operating Activities
- 485.49
- Cashfrom Investing Activities
- -135.1
- Cashfrom Financing Activities
- -142.93
- Net Changein Cash
- 212.01
- Period
- 2020
- Total Revenue
- 4632.32
- Selling/ General/ Admin Expenses Total
- 2841.78
- Depreciation/ Amortization
- 291.73
- Other Operating Expenses Total
- 13.72
- Total Operating Expense
- 4251.83
- Operating Income
- 380.49
- Net Income Before Taxes
- 239.36
- Net Income
- 57.94
- Diluted Normalized EPS
- 0.24
- Period
- 2020
- Total Assets
- 11347.82
- Total Liabilities
- 4686.73
- Total Equity
- 6661.09
- Tangible Book Valueper Share Common Eq
- 37.94
- Period
- 2020
- Cashfrom Operating Activities
- 171.54
- Cashfrom Investing Activities
- 60.42
- Cashfrom Financing Activities
- -861.61
- Net Changein Cash
- -626.58
- Period
- 2019
- Total Revenue
- 4469.36
- Selling/ General/ Admin Expenses Total
- 3107.42
- Depreciation/ Amortization
- 231.81
- Other Operating Expenses Total
- 7.24
- Total Operating Expense
- 4686.9
- Operating Income
- -217.54
- Net Income Before Taxes
- -110.1
- Net Income
- -298.94
- Diluted Normalized EPS
- -1.84
- Period
- 2019
- Total Assets
- 11951.27
- Total Liabilities
- 5350.47
- Total Equity
- 6600.8
- Tangible Book Valueper Share Common Eq
- 36.95
- Period
- 2019
- Cashfrom Operating Activities
- -87.62
- Cashfrom Investing Activities
- -3322.74
- Cashfrom Financing Activities
- 4256.61
- Net Changein Cash
- 798.76
- Period
- 2018
- Total Revenue
- 4560.81
- Selling/ General/ Admin Expenses Total
- 3073.19
- Depreciation/ Amortization
- 235.61
- Other Operating Expenses Total
- 10.73
- Total Operating Expense
- 5371.9
- Operating Income
- -811.09
- Net Income Before Taxes
- -911.77
- Net Income
- -1009.22
- Diluted Normalized EPS
- -8.36
- Period
- 2018
- Total Assets
- 8621.69
- Total Liabilities
- 4559.97
- Total Equity
- 4061.72
- Tangible Book Valueper Share Common Eq
- 36.37
- Period
- 2018
- Cashfrom Operating Activities
- 492.9
- Cashfrom Investing Activities
- -335.37
- Cashfrom Financing Activities
- -672.05
- Net Changein Cash
- -512.6
- Period
- 2024-03-31
- Total Revenue
- 1785.88
- Selling/ General/ Admin Expenses Total
- 641.3
- Depreciation/ Amortization
- 92.23
- Other Operating Expenses Total
- 349.86
- Total Operating Expense
- 1493.93
- Operating Income
- 291.95
- Net Income Before Taxes
- 271.38
- Net Income
- 178.73
- Diluted Normalized EPS
- 2.34
- Period
- 2024-03-31
- Total Assets
- 13288.78
- Total Liabilities
- 5625.88
- Total Equity
- 7662.9
- Tangible Book Valueper Share Common Eq
- 40.47
- Period
- 2024-03-31
- Cashfrom Operating Activities
- 1100.08
- Cashfrom Investing Activities
- -886.35
- Cashfrom Financing Activities
- -86.46
- Net Changein Cash
- 124.52
- Period
- 2023-12-31
- Total Revenue
- 1679.68
- Selling/ General/ Admin Expenses Total
- 644.73
- Depreciation/ Amortization
- 86.91
- Other Operating Expenses Total
- 357.21
- Total Operating Expense
- 1474.91
- Operating Income
- 204.77
- Net Income Before Taxes
- 183.15
- Net Income
- 134.67
- Diluted Normalized EPS
- 1.71
- Period
- 2023-12-31
- Period
- 2023-12-31
- Period
- 2023-09-30
- Total Revenue
- 1769.95
- Selling/ General/ Admin Expenses Total
- 654.97
- Depreciation/ Amortization
- 84.12
- Other Operating Expenses Total
- 372.08
- Total Operating Expense
- 1520.21
- Operating Income
- 249.74
- Net Income Before Taxes
- 232.71
- Net Income
- 173.72
- Diluted Normalized EPS
- 2.26
- Period
- 2023-09-30
- Total Assets
- 12785.37
- Total Liabilities
- 5175.21
- Total Equity
- 7610.16
- Tangible Book Valueper Share Common Eq
- 39.89
- Period
- 2023-09-30
- Cashfrom Operating Activities
- 475.46
- Cashfrom Investing Activities
- -385.61
- Cashfrom Financing Activities
- -145.73
- Net Changein Cash
- -56.99
- Period
- 2023-06-30
- Total Revenue
- 1657.41
- Selling/ General/ Admin Expenses Total
- 638.04
- Depreciation/ Amortization
- 79.24
- Other Operating Expenses Total
- 348.41
- Total Operating Expense
- 1462.71
- Operating Income
- 194.7
- Net Income Before Taxes
- 170.73
- Net Income
- 111.76
- Diluted Normalized EPS
- 1.47
- Period
- 2023-06-30
- Period
- 2023-06-30
- Period
- 2023-03-31
- Total Revenue
- 1642.7
- Selling/ General/ Admin Expenses Total
- 602.64
- Depreciation/ Amortization
- 81.78
- Other Operating Expenses Total
- 386.8
- Total Operating Expense
- 1443.07
- Operating Income
- 199.64
- Net Income Before Taxes
- 183.41
- Net Income
- 132.55
- Diluted Normalized EPS
- 1.65
- Period
- 2023-03-31
- Total Assets
- 12433.6
- Total Liabilities
- 5191.34
- Total Equity
- 7242.26
- Tangible Book Valueper Share Common Eq
- 35.3
- Period
- 2023-03-31
- Cashfrom Operating Activities
- 822.22
- Cashfrom Investing Activities
- -373.7
- Cashfrom Financing Activities
- -471.22
- Net Changein Cash
- -21.46
- Period
- 2022-12-31
- Total Revenue
- 1559.88
- Selling/ General/ Admin Expenses Total
- 591.51
- Depreciation/ Amortization
- 82.75
- Other Operating Expenses Total
- 333.68
- Total Operating Expense
- 1354.72
- Operating Income
- 205.16
- Net Income Before Taxes
- 186.1
- Net Income
- 129.56
- Diluted Normalized EPS
- 1.6
- Period
- 2022-12-31
- Period
- 2022-12-31
Forecast
Income Sheet (In Cr)
Net Income Vs Revenue
Returns Metrics (In Cr)
ROA Vs ROE
Forecast
Balance Sheet
Asset vs Liability
Forecast
Cash Flow
Operating vs Investing
Fortis Healthcare Technical
Moving Average
SMA
- 5 Day485.36
- 10 Day486.31
- 20 Day473.3
- 50 Day455.66
- 100 Day437.77
- 300 Day402.08
Fortis Healthcare Peers
- Price
- Ratio
- Name
- Latest Price
- Change
- % Change
- 52W High
- 52W Low
- Mkt. Cap
- Apollo Hospitals Enterprise
- 6163
- 24.75
- 0.4
- 6871.3
- 4727
- 88614.49
- Max Healthcare Institute
- 921.3
- 40.8
- 4.63
- 979.8
- 509.05
- 89542.07
- Fortis Healthcare
- 478.35
- -3
- -0.62
- 509.85
- 298
- 36113.42
- Narayana Hrudayalaya
- 1204.4
- 7.95
- 0.66
- 1445.05
- 972.05
- 24461.34
- Dr. Lal Pathlabs
- 2751.5
- 4.85
- 0.18
- 2889.45
- 1943.2
- 22896.08
- Name
- P/E (X)
- P/B (X)
- ROE %
- OPM
- Apollo Hospitals Enterprise
- 100.87
- 13.05
- 13.57
- 4.84
- Max Healthcare Institute
- 81.13
- 10.17
- 10.89
- 15.02
- Fortis Healthcare
- 62.4
- 4.78
- 5.07
- 7.63
- Narayana Hrudayalaya
- 30.78
- 8.42
- 23.44
- 9.72
- Dr. Lal Pathlabs
- 63.24
- 12.23
- 21.32
- 15.99
Fortis Healthcare Shareholding
Shareholding Pattern
Shareholding Trend
Shareholding(%) v/s Date
Corporate Actions
- Board Meeting
- AGM
- Dividends
- Bonus
- Split
- Rights
- Meeting Date
- Purpose
- 23-May-24
- Audited Results & Final Dividend
- 07-Feb-24
- Quarterly Results
- 10-Nov-23
- Quarterly Results
- 04-Aug-23
- Quarterly Results
- 23-May-23
- Audited Results & Final Dividend
- 10-Feb-23
- Quarterly Results
- 11-Nov-22
- Quarterly Results
- 05-Aug-22
- Quarterly Results
- 25-May-22
- Audited Results
- 11-Feb-22
- Quarterly Results
- Meeting Date
- Announced on
- Purpose
- 03-Jan-24
- 04-Dec-23
- POM
- 08-Dec-23
- 07-Nov-23
- POM
- 09-Sept-23
- 09-Aug-23
- POM
- 01-Aug-23
- 23-May-23
- AGM
- 01-Jul-23
- 02-Jun-23
- POM
- 01-Aug-22
- 21-Jun-22
- AGM
- 09-Apr-22
- 07-Mar-22
- POM
- 18-Feb-22
- 13-Jan-22
- POM
- 30-Jul-21
- 29-Jun-21
- AGM
- 16-Mar-21
- 12-Feb-21
- POM
- Announced on
- Record Date
- Ex-Dividend
- Dividend Value
- 23-May-24
- -
- -
- 1
- 24-May-23
- 20-Jul-23
- 20-Jul-23
- 1
![No data](https://www.livemint.com/lm-img/dev/null-data.png)
![No data](https://www.livemint.com/lm-img/dev/null-data.png)
![No data](https://www.livemint.com/lm-img/dev/null-data.png)